Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

PExA recruit expert in the field of BiomarkerDiscovery

PExA AB (”PExA”) that develop and commercialise an instrument which enable researchers to collect biological material from lung in an non-invasive way to study respiratory diseases, announces the recruitment of Jörgen Östling (PhD), a senior life science researcher.  Jörgen will assume his new role as ‘Manager, Bio­chemical Analysis and Research’ by January 15, 2018.Jörgen Östling holds a PhD in microbiology and has extensive experience from proteomics and bioinformatics. He has worked more than 20 years within the pharma industry, whereof the last six years focusing on the identification

ChromoGenics’ order to deliver dynamic glass to the Swedish Energy Agency’s new headquarters completed

ChromoGenics AB (publ) has completed the order to deliver dynamic glass to the Swedish Energy Agency's newly opened headquarters in Eskilstuna. ChromoGenics’ dynamic glass, installed in the entrance to the new headquarters, will contribute to increased energy efficiency and indoor comfort.During the third quarter, ChromoGenics delivered and installed ConverLight™ dynamic glass to the Swedish Energy Agency's new headquarters in Eskilstuna, which was recently inaugurated. A building of a former metal foundry has been transformed into an activity-based office, fully adapted to the activities

Invitation – Presentation and conference call Hoist Finance third quarter 2017 report

Hoist Finance will publish its third quarter results on Thursday, 26thof October, 2017, at approximately 08.00 AM (CET). A combined presentation and conference call for investors, analysts and media will be held at 09.30 AM (CET). The report will be presented at the company office, Sturegatan 6, by Jörgen Olsson, CEO and Pontus Sardal, CFO. The presentation will also be broadcasted live at: https://tv.streamfabriken.com/hoist-finance-q3-2017 Dial-in details for the conference call: SE: +46 85 664 2666 UK: +44 20 3008 9804 US: +1 855 753 2236 To participate at the company

Husqvarna Group scales back business with large U.S. retail customer

The Consumer Brands Division of the Husqvarna Group will significantly reduce the volume of business with one of its biggest U.S. retail customers, following the strategy to focus resources on accounts with more attractive opportunities. The Division has started to adjust capacity and other measures to mitigate short-term negative financial effects. Because of the reduced volume, the Consumer Brands Division’s net sales for 2018 is expected to decline by some SEK 1 Bn compared to 2017. This will delay the operating income improvement trajectory. “We are committed to a strong, future-

Handelsbanken’s interim report for January-September 2017 will be presented on October 18

Handelsbanken will present its results for January­‑September 2017 in Stockholmon October 18, 2017, at 8:30 a.m. CET, at a meeting with the media and analysts. The interim report for January‑September 2017 will be published at 7:00 a.m. CET,on October 18, 2017. A telephone conference will be held at 11:00 a.m. CET (5:00 a.m. EST), whenRolf Marquardt, CFO, will present and comment on the results. There will also be time for questions from the participants. UK number: +44 203–364 5374Swedish number: +46 8–505 564 74US number: +1 855–753 2230 Instructions1.    Dial

No serious adverse effects in GLP-tox preliminary study for Temodex

Double Bond Pharmaceutical (DBP) has initiated the toxicological evaluation of the company's drug candidate against brain cancer, Temodex, as announced earlier. This study package is intended to demonstrate the safety of Temodex in the brain in rats to clarify the improved safety profile seen in previous studies. The toxicological package begins with a preliminary study followed by the major GLP study.The first animals have now been dosed in the preliminary study without observing any serious adverse effects."The preliminary results we have obtained are entirely in line with the

Capio acquires yet another hospital and radiology unit in Denmark

Capio has acquired Viborg Privathospital and MR Scanner Aarhus in an asset deal. The clinic in the city of Viborg is primarily specialized in orthopedics and general surgery while the operations at MR Scanner Aarhus comprise radiological examinations. Net sales in 2017 are estimated to MDKK 36. The acquisition is complementary to Capio’s existing opera­tions on Jutland and some synergies are expected with the units in Skørping and Aarhus.The city of Viborg is located centrally on Jutland, less than an hour’s drive from Capio’s two units in Skørping on North Jutland and in Aarhus. The

BGB324, BerGenBio's Selective First-in-Class AXL Inhibitor, Featured in 3 Clinical Presentations at 18th World Conference on Lung Cancer in Yokohama

Bergen, Norway, October 16, 2017 – BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective Axl kinase inhibitors for multiple cancer indications, announces presentations on three ongoing Phase 2 clinical trials with BGB324 in lung cancer patients at the 18th World Conference on Lung Cancer in Yokohama, Japan.BGB324, a first-in-class selective Axl inhibitor, is being investigated in three Phase 2 clinical trials across the three standard-of-care treatment regimens available to patients with non-small-cell lung cancer (NSCLC): these trials seek to

TA Associates, L.P. and Barbara Bergström reorganise their holdings in Internationella Engelska Skolan i Sverige Holdings II AB (publ)

Today, Internationella Engelska Skolan i Sverige Holdings II AB (publ) (“IES”) has been informed by its major shareholders that they will reorganise their joint holdings in IES. The reorganisation is expected to be concluded in the coming days.As made public in the prospectus in connection with the listing of IES’s shares on Nasdaq Stockholm last year, IES’s major shareholders, Mountainstream Holding II S.à.r.l., advised by TA Associates, L.P., (“TA Associates”) and Barbara Bergström (the “Shareholders”), hold their shares through a joint venture company, Internationella Engelska Skolan i

Invitation to the presentation of Ovako's third quarter 2017 report

On Wednesday 25 October 2017, at 08:00 CET, Ovako Group AB will publish its third quarter 2017 report. Financial analysts and investors in Ovako's senior secured notes are invited to participate in a telephone and web conference on the same day at 15:00 CET where the Q3 report will be presented. The event will be hosted by Ovako's CFO, Johan Ryrberg, and the presentation will be held in English. The presentation can be followed live via telephone or online, or afterwards via a recording posted on Ovako's website. Slides used in the presentation will be made available on http://www.

Read original

Stora Enso shares converted

STORA ENSO OYJ STOCK EXCHANGE RELEASE 16 October 2017 at 9.00 EESTDuring the 1–29 September 2017 conversion period there was two conversions and a total of 34 000 A shares were converted into R shares. The shares were recorded in the Finnish trade register today, 16 October 2017, and trading in the new R shares will start on 17 October 2017.Breakdown of shares after conversion: A shares 176 412 320R shares 612 207 667Total 788 619 987 Each A share and each ten R shares carry one vote. The total amount of votes after the conversion is at least 237 633 087.For further

Nevisense presented as one of the top ten most important news stories within skin cancer for dermatologists at US congress

SciBase has participated in, exhibited and demonstrated their product Nevisense, for early detection of malignant melanoma at the Fall Clinical Dermatology Conference in Las Vegas. The congress was held between 12th and 15 of October and is one of the largest and important national congresses within dermatology. At the congress Darrel S. Rigel, MD and Clinical Professor of Dermatology at the New York University Medical Center presented Nevisense as one of the top ten most important news stories within skin cancer. Nevisense was also presented in a scientific poster by Dr Ryan Svoboda. The

Archer named Innovation Award finalist

10/16/2017  The ICoTA European Chapter innovation Award is intended to recognise the application of technological innovation in the area of well intervention. The shortlisting of the ComTrac® system as a finalist is tribute to the hard work of both Archer and our development partner C6 Technologies in bringing the benefits of carbon composite materials to well intervention operations. The ComTrac® rod combines the high strength and low weight of carbon fibre materials with an electrical conductor to allow mechanical intervention and precision logging to be conducted within the same

Sweco to provide several planning and design services for Grand Central project in Frankfurt am Main

Sweco has been commissioned by a joint venture of Groß & Partner Grundstücksentwicklungsgesellschaft mbH and Phoenix Real Estate Development GmbH to plan and design a vital part of the Grand Central project in Frankfurt am Main, a large office project beside the city’s central station.The area next to Frankfurt main station, one of Europe’s busiest, is about to undergo a significant transformation. 18,000 square meters, including a group of buildings from the 1970’s, will be completely redesigned. A team of experts from Sweco and the newly acquired Jo. Franzke Generalplaner GmbH will

Read original

Over 97 percent sales rate in SSM’s ongoing production at end of third quarter

The number of one- and two-room apartments sold in the Greater Stockholm area went up by 5.7 percent in the third quarter 2017 compared with the corresponding period in 2016. SSM, which is the market leading property developer in the Stockholm region within affordable housing for one- and two-person households, is continuing to meet this target group’s genuine need of housing. At the end of the third quarter, SSM had 1,414 homes in production with a sales rate of 97.1 percent.  The demand for small apartments in Stockholm County continues to be strong. According to Svensk Mäklarstatistik,

Mullvad joins one of world's largest internet exchanges

16 October 2017 (Gothenburg, Sweden) – Mullvad VPN, in its continued efforts to improve its infrastructure, has, via 31173 Services AB, established a 10-Gbit connection to one of the world's biggest internet exchange points, located in Amsterdam. "We are excited about the ability to now peer with 800 other international networks at the most widely used exchange service," says Mullvad CEO Jan Jonsson.Public peering allows for the parties within the exchange to send their traffic directly to one another rather than taking a longer route over the public Internet. Peering also improves

Sweat at the gym, Save at home.

Boo Energy becomes the first energy company in the world to offer customers an opportunity to lower their electricity bills by exercising.Boo Energy, one of Sweden’s most innovative energy companies has a new motivational health program for their customers as the country moves into the colder months of the year. “Get fit and healthy and at the same time lower your electricity bill”. Energy you burn at the gym, running or just during your relaxing walk in the park, you’ll get compensated for on your electricity bill. (860 KCal = 1kWh).          Boo Energy is a small energy company founded

Multiconsult ASA – Repurchase of own shares

On 13 October 2017, Multiconsult ASA ("Multiconsult") purchased 2 000 of its own shares at an average price of NOK 87.38 per share. The shares were purchased in accordance with the Company's share repurchase programme as announced on 22 September 2017. The shares were acquired on Oslo Børs.Following this transaction Multiconsult holds 68 981 of its own shares. For further information, please contact: Investor relations:      Mirza Koristovic, Head of Investor Relations      Phone: +47 93 87 05 25      E-mail: ir@multiconsult.no Media:      Gaute Christensen, VP

New antibiotic resistance genes found

Researchers at Chalmers University of Technology and the University of Gothenburg, Sweden, have found several previously unknown genes that make bacteria resistant to last-resort antibiotics. The genes were found by searching large volumes of bacterial DNA and the results are published  in the scientific journal Microbiome. The increasing number of infections caused by antibiotic-resistant bacteria is a rapidly growing global problem. Disease-causing bacteria become resistant through mutations of their own

Swedish Design Moves New York at Archtober 2017

A thematic program investigating varying perspectives of Democratic Architecture(New York, NY) October 13, 2017 - Swedish Design Moves New York, a program celebrating Swedish innovation through the lens of architecture and design, announces a week of programming in New York, October 24-28. Focusing on democratic architecture and global best practices, Sweden has teamed up with the Center for Architecture and Van Alen Institute to host a series of cross-disciplinary panels and conversations, curated by STHLMNYC. The exhibition Aiming for Democratic Architecture, curated by Architects Sweden

Peter Fredell resigns from Seamless’ Board

Peter Fredell has informed the Chairman of the Board, John Longhurst, that Fredell, effective immediately, resigns from Seamless Distribution AB’s Board of Directors. For further information, please contact:John Longhurst, Chairman of the Board, john.longhurst@seqr.com, +46 8 564 878 00 This information is information that Seamless Distribution AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. This information was submitted for publication, through the agency of the contact person set out above, at CET 17:30 on October 13, 2017. About SeqrSeqr is

Young Cultural Innovators to convene in Salzburg for fourth Global Forum for Young Cultural Innovators

The network expands to more than 200 creative change-makers across the worldSALZBURG, Austria, October 12 – Young cultural innovators from across Canada will join artists, entrepreneurs, designers, dancers, architects, poets, and a host of other young creatives from across the world in Salzburg, Austria from October 14-19 for the Salzburg Global Forum for Young Cultural Innovators (YCI Forum). Each year, the YCI Forum brings together over 50 of the brightest minds from varying geographic and cultural backgrounds with the goal of developing their practical skills, reflecting on their

Crown Energy publishes prospectus and new financial and other information included in the prospectus

Crown Energy AB (publ) (”Crown Energy” or the ”Company”) today publishes  a prospectus regarding the admission to trading of the Company’s ordinary shares, which were converted from class C shares, on NGM Equity (“NGM”). The prospectus contains, due to regulatory requirements, new financial information attributable to the Company’s equity and liabilities as well as net indebtedness as of 31 July 2017 that has not previously been published. Furthermore, the prospectus contains a valuation statement issued by an external evaluator regarding the Company’s property portfolio.Publication of

Cyxone to research additional autoimmune conditions

In collaboration with the Medical University of Vienna, Cyxone is set to conduct a study into inflammatory bowel disease involving a cyclotide in established animal models. The study will begin early in 2018.Work on developing T20K for multiple sclerosis has indicated that cyclotides have excellent drug properties. The cellular processes on which T20K has an effect have been found by independent researchers to also be significant for autoimmune conditions. The inflammatory bowel disease study is part of Cyxone's strategy to investigate whether cyclotides under existing patents should be

There are no items matching the current filter
There are no more items matching the current filter
Back to top